January 12, 2026 – Augurex was featured by Moira Gunn of NPR’s BioTech Nation as one of her Top 5 interviews for the J.P. Morgan Healthcare Conference.
Listen to the interview here:
You’ve Had Back Pain for 7-10 Years? Neil Klompas, CEO, Augurex
The BioTech Nation Top 5 highlights companies shaping the future of biotechnology and addressing meaningful unmet needs in patient care. Augurex was featured alongside four other innovators, with the conversation focusing on the patient journey behind chronic back pain and why so many individuals spend 7 to 10 years searching for the right diagnosis.
The interview highlighted SPINEstat® (Anti-14-3-3eta Multiplex test), Augurex’s diagnostic blood test for axial spondyloarthritis, and its potential to help address long-standing gaps in back pain care. SPINEstat has been granted FDA Breakthrough Device Designation, recognizing its potential to provide more timely and impactful diagnostic insight for patients with suspected inflammatory back pain.
We thank Moira Gunn and BioTech Nation for the opportunity to be part of this special JPM feature and to share Augurex’s work with a global audience.